GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (OTCPK:RCDTF) » Definitions » FCF Margin %

Recordati SpA (Recordati SpA) FCF Margin % : 10.66% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Recordati SpA FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Recordati SpA's Free Cash Flow for the three months ended in Dec. 2023 was $61 Mil. Recordati SpA's Revenue for the three months ended in Dec. 2023 was $574 Mil. Therefore, Recordati SpA's FCF Margin % for the quarter that ended in Dec. 2023 was 10.66%.

As of today, Recordati SpA's current FCF Yield % is 1.46%.

The historical rank and industry rank for Recordati SpA's FCF Margin % or its related term are showing as below:

RCDTF' s FCF Margin % Range Over the Past 10 Years
Min: -8.41   Med: 18.85   Max: 25.59
Current: 7.37


During the past 13 years, the highest FCF Margin % of Recordati SpA was 25.59%. The lowest was -8.41%. And the median was 18.85%.

RCDTF's FCF Margin % is ranked better than
70.14% of 1028 companies
in the Drug Manufacturers industry
Industry Median: -0.025 vs RCDTF: 7.37


Recordati SpA FCF Margin % Historical Data

The historical data trend for Recordati SpA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA FCF Margin % Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.41 18.77 25.59 19.71 4.90

Recordati SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.39 29.34 -36.93 10.66 23.37

Competitive Comparison of Recordati SpA's FCF Margin %

For the Drug Manufacturers - General subindustry, Recordati SpA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Recordati SpA's FCF Margin % falls into.



Recordati SpA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Recordati SpA's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=111.292/2270.808
=4.90 %

Recordati SpA's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=61.183/573.781
=10.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Recordati SpA FCF Margin % Related Terms

Thank you for viewing the detailed overview of Recordati SpA's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA (Recordati SpA) Business Description

Traded in Other Exchanges
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (Recordati SpA) Headlines

From GuruFocus

Recordati: Isturisa® (Osilodrostat) Approved In The U.S.

By PRNewswire PRNewswire 03-09-2020